Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method
Treament | Trials | |||||
---|---|---|---|---|---|---|
clinical deterioration | clinical improvement | deaths | viral clearance | |||
IFN alpha | - | 0.68 [0.21; 2.20], 1 RCT, I2=0% inconclusive result | 2.45 [0.21; 28.37], 2 RCTs, I2=0% inconclusive result | 2.69 [1.48; 4.87], 2 RCTs, I2=0% moderate degree of certainty | ||
recombinant super-compound interferon rSIFN-co | 0 | - | - | - | - | |
SNG001 inhaled interferon beta | 0 | - | - | - | - |